Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Costa Rica HPV Vaccine Trial
NCT00128661Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2004
- Primary completion
- Dec 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Human papillomavirus type 16 L1 capsid protein residues 2-471 antigen in cervical intraepithelial neoplasia (CIN), Cervical Cancer (CC), sponsored by GSK. Started Jun 2004; status: completed.
02
Drugs
Human papillomavirus type 16 L1 capsid protein residues 2-471 antigen
03
Conditions
cervical intraepithelial neoplasia (CIN)Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00128661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00128661.